India's Richest People 2026 edition · 1 director · Source: Hurun India
- #912 Vishnukant Bhutada & family ₹3,200 Cr
Sampra Corporate Holdings Private Limited
Sampra Corporate Holdings Private Limited - pharma in Raichur, Karnataka, India. FY 2026 financials & compliance.
Active Private Limited Company pharma
Revenue · FY 2025
₹67.87 Lakh
▼ 6% YoY
Net profit · FY 2025
₹3.53 Cr
Latest filing
EBITDA · FY 2025
₹4.35 Cr
Latest filing
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.51 Cr
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Sampra Corporate Holdings Private Limited
Data last updated:
Sampra Corporate Holdings Private Limited is a private limited company based in Raichur, Karnataka, India, a subsidiary of Shilpa Medicare Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 June 2021 and has been in existence for over 5 years.
Its director Vishnukant Bhutada and family are #912 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U64200KA2021PTC148960.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.51 Cr. It is led by directors Ramakant Innani and Vishnukanth Chaturbhuj Bhutada.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #12 – 6 – 214/A – 1 Hyderabad Road Raichur, Karnataka, India – 584135.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.87 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹3.53 Cr and EBITDA of ₹4.35 Cr.
Company details
CIN U64200KA2021PTC148960
Registration Number 148960
Incorporation Date 30 June 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Shilpa Medicare Limited
CIN history
Sampra Corporate Holdings has one previous CIN (Corporate Identification Number): U24290KA2021PTC148960. The current CIN is U64200KA2021PTC148960, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U64200KA2021PTC148960 | Current |
| U24290KA2021PTC148960 | Previous |
Recognitions & Rankings of Sampra Corporate Holdings
Contact details
Sampra Corporate Holdings Private Limited's registered office is in Raichur, Karnataka.
- Registered Address#12 – 6 – 214/A – 1 Hyderabad Road Raichur, Karnataka, India – 584135
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Sampra Corporate Holdings Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Sampra Corporate Holdings Private Limited
FY 2025 filings availableSampra Corporate Holdings Private Limited reported revenue of ₹67.87 Lakh (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹67.87 Lakh ▼ 6%
Net profit · FY 2025
₹3.53 Cr
EBITDA · FY 2025
₹4.35 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▲ 257%
Revenue fell 6% in the latest year. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹4.35 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹3.53 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sampra Corporate Holdings Private Limited, buy the company report.
Board of directors of Sampra Corporate Holdings Private Limited
Sampra Corporate Holdings has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramakant Innani Also directs: Shilpa Pharma Lifesciences Limited, Shilpa Biologicals Private Limited, Shilpa Lifesciences Private Limited and 5 more | Director | 30 Jun 2021 | 5 Years 3 Months | Current |
| Vishnukanth Chaturbhuj Bhutada Also directs: Ayodhya Sarayu Infra LLP, Shilpa Medicare Limited, Shilpa Pharma Lifesciences Limited and 5 more | Director | 30 Jun 2021 | 5 Years 3 Months | Current |
Peer comparison
Sampra Corporate Holdings Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biotechnology, Holding Company), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kentron Biotechnology Private Limited | ₹70.36 Lakh (FY 2020) | -61.0% | Bangalore, Karnataka, India | |||
| Clinnovo Research Labs Private Limited | ₹69.78 Lakh (FY 2025) | 15.0% | Hyderabad, Telangana, India | |||
| Charuhasa Biotechnologies Private Limited | ₹69.67 Lakh (FY 2024) | 481.0% | Chitvel, Andhra Pradesh, India | |||
| GVS Biotech Private Limited | ₹69.61 Lakh (FY 2025) | -15.0% | Banga, Punjab, India | |||
| Novamedix Biotechnology Limited | ₹69.5 Lakh (FY 2025) | 483.0% | Lucknow, Uttar Pradesh, India | |||
| Sampra Corporate Holdings Private Limitedthis company | ₹67.87 Lakh (FY 2025) | ₹3.53 Cr | -6.0% | Raichur, Karnataka, India | ||
| Cloudflake Holdings Private Limited | ₹67.8 Lakh (FY 2025) | Anand, Gujarat, India | ||||
| Overseas Keralites Investment and Holding Limited | ₹67.56 Lakh (FY 2025) | 11.0% | Thiruvananthapuram, Kerala, India | |||
| Raksha Holdings Private Limited | ₹67.54 Lakh (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Ritusri Life Sciences Private Limited | ₹67.48 Lakh (FY 2023) | -3.0% | Hyderabad, Telangana, India | |||
| Finvesco Holdings Private Limited | ₹67.33 Lakh (FY 2025) | 630.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sampra Corporate Holdings Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sampra Corporate Holdings Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sampra Corporate Holdings Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sampra Corporate Holdings Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sampra Corporate Holdings Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Ramakant Innani was appointed as Director on 30 Jun 2021.
AGM
Sampra Corporate Holdings Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sampra Corporate Holdings Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Ramakant Innani was appointed as Director.
Appointed
Vishnukanth Chaturbhuj Bhutada was appointed as Director.
Incorporation
30 Jun 2021
Sampra Corporate Holdings Private Limited was registered on 30 Jun 2021 with Roc Bangalore & aged 5 years 3 months as per MCA records.
Frequently asked questions
Sampra Corporate Holdings is an active private limited company based in Raichur, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 June 2021 (5+ years old) and is registered under CIN U64200KA2021PTC148960.
Sampra Corporate Holdings has 2 current directors:
- Ramakant Innani - Director
- Vishnukanth Chaturbhuj Bhutada - Director
The latest financial statements of Sampra Corporate Holdings on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Sampra Corporate Holdings is U64200KA2021PTC148960. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sampra Corporate Holdings was incorporated on 30 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Sampra Corporate Holdings by revenue are Kentron Biotechnology Private Limited, Clinnovo Research Labs Private Limited, Charuhasa Biotechnologies Private Limited, GVS Biotech Private Limited, Novamedix Biotechnology Limited and 5 more, all in the Biotechnology industry (Biotechnology, Holding Company).
Ramakant Innani was appointed as Director on 30 Jun 2021. Vishnukanth Chaturbhuj Bhutada was appointed as Director on 30 Jun 2021.
The registered office of Sampra Corporate Holdings is at #12 – 6 – 214A – 1 Hyderabad Road Raichur, Karnataka, India – 584135.
Sampra Corporate Holdings operates in the pharma industry, in the drug formulation and development segment.
Sampra Corporate Holdings can be reached at its registered office: #12 – 6 – 214A – 1 Hyderabad Road Raichur, Karnataka, India – 584135.
Sampra Corporate Holdings is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.